How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test examines predispositions in key peptide receptor pathways, including variants in GLP1R (rs6923761), GIPR (rs1800437), and related metabolic genes
In comparison, available doses of Trulicity are 0.75 mg, 1.5 mg, 3 mg, and 4.5 mg per 0.5 ml solution
For patients interested in optimizing their treatment selection after weaning, PlexusDx's Precision Peptide Genetic Test ($99 add-on after your first month of treatment) analyzes 14 weight regulation pathways and 49 peptides to reveal genetic variants affecting GLP-1 receptor sensitivity, GIPR signaling, and metabolic control
10.1073/pnas.1802691115 13
Each approaches the problem from a different angle, and understanding these options helps build a comprehensive picture of how peptide research is reshaping allergy management
Weight loss drug Wegovy has been approved for use in Israel by the Health Ministry